Chemours (NYSE:CC) Downgraded to Hold at StockNews.com

Chemours (NYSE:CC – Get Rating) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Saturday.

CC has been the subject of a number of other research reports. Credit Suisse Group dropped their price objective on Chemours from $27.00 to $25.00 in a report on Friday, April 28th. Royal Bank of Canada boosted their target price on Chemours from $35.00 to $36.00 in a research note on Monday, May 1st. Citigroup boosted their target price on Chemours from $33.00 to $35.00 and gave the company a “neutral” rating in a research note on Monday, February 13th. UBS Group raised Chemours from a “neutral” rating to a “buy” rating and boosted their target price for the company from $31.00 to $43.00 in a research note on Tuesday, January 24th. Finally, The Goldman Sachs Group boosted their target price on Chemours from $34.00 to $38.00 and gave the company a “neutral” rating in a research note on Tuesday, February 14th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $36.11.

Chemours Price Performance

Shares of CC stock opened at $29.68 on Friday. The stock has a 50 day moving average of $29.17 and a two-hundred day moving average of $31.44. The company has a current ratio of 1.84, a quick ratio of 0.98 and a debt-to-equity ratio of 2.93. Chemours has a 12 month low of $23.58 and a 12 month high of $44.95. The company has a market capitalization of $4.43 billion, a P/E ratio of 9.57, a P/E/G ratio of 0.91 and a beta of 1.87.

Chemours (NYSE:CC – Get Rating) last released its quarterly earnings results on Friday, April 28th. The specialty chemicals company reported $0.98 earnings per share for the quarter, beating analysts’ consensus estimates of $0.62 by $0.36. Chemours had a return on equity of 53.44% and a net margin of 7.45%. The firm had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.46 billion. During the same period last year, the firm posted $1.46 EPS. The business’s revenue was down 12.9% on a year-over-year basis. As a group, equities analysts expect that Chemours will post 3.97 EPS for the current year.

Insider Transactions at Chemours

In other news, insider Alisha Bellezza sold 27,716 shares of the business’s stock in a transaction dated Monday, March 6th. The stock was sold at an average price of $35.47, for a total transaction of $983,086.52. Following the sale, the insider now directly owns 43,931 shares in the company, valued at $1,558,232.57. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.63% of the company’s stock.

Hedge Funds Weigh In On Chemours

A number of institutional investors have recently modified their holdings of CC. Ameritas Advisory Services LLC bought a new stake in Chemours during the first quarter worth $29,000. Lindbrook Capital LLC grew its holdings in Chemours by 117.3% during the fourth quarter. Lindbrook Capital LLC now owns 969 shares of the specialty chemicals company’s stock worth $30,000 after buying an additional 523 shares in the last quarter. Operose Advisors LLC bought a new stake in Chemours during the first quarter worth $33,000. Tanglewood Legacy Advisors LLC bought a new stake in Chemours during the fourth quarter worth $41,000. Finally, GPS Wealth Strategies Group LLC bought a new stake in Chemours during the first quarter worth $47,000. 71.89% of the stock is owned by institutional investors and hedge funds.

Chemours Company Profile

(Get Rating)

The Chemours Co is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial.